PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia.\', \'Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia.\', \'FROM Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy.\', \'Papa Giovanni XXIII Hospital, Bergamo, Italy.\', \'Columbia University Irving Medical Center, New York City, New York, USA.\', \'The Christie NHS Foundation Trust, Manchester, UK.\', \'Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.\', \'Dana Farber Cancer Institute, Boston, Massachusetts, USA.\', \'Segal Cancer Centre Jewish General Hospital, McGill University, Montreal, Québec, Canada.\', \'Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.\', \'Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario, Canada.\', \'Netherlands Cancer Institute, Amsterdam, The Netherlands.\', \'Gustave Roussy and Paris-Saclay University, Villejuif, France.\', \'Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.\', \'Royal North Shore Hospital and Mater Hospital, Sydney, New South Wales, Australia.\', \'Comprehensive Cancer Center Erlangen - EMN, University Medical Center Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.\', \'University Hospital Essen & German Cancer Consortium, Partner Site, Essen, Germany.\', \'European Institute of Oncology, Milan, Italy.\', \'Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy.\', \'Technical University of Munich, German Cancer Consortium (DKTK), Munich, Germany.\', \'University Hospital Schleswig-Holstein, Kiel, Germany.\', \'University Medical Center Utrecht, Utrecht, The Netherlands.\', \'University of Manchester, Manchester, UK.\', \'Unit of Medical Oncology, University of Perugia, Perugia, Italy.\', \'Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia georgina.long@sydney.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00193110.1136/jitc-2020-001931
?:doi
?:hasPublicationType
?:journal
  • Journal for immunotherapy of cancer
is ?:pmid of
?:pmid
?:pmid
  • 33468556
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.798
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33468556>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33468556>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all